| Followers | 14 |
| Posts | 1585 |
| Boards Moderated | 0 |
| Alias Born | 01/17/2017 |
Thursday, February 22, 2018 4:17:27 PM
you've been in all these penny stocks for 3+ years, staying long, never making any money and wasting your entire day posting non-stop on all these boards getting beat up left and right....why? 1000's upon 1000's of posts of nonsense defending stinky pinky companies and making no money by flipping...please explain? Also, you sucker people in by making them think you know what you're talking about, when that's so far from the case....perfect example, your chart theory and you stated this thing was headed to 1.30 in the near-term (chart shows no resistance until 1.30ish), when in actuality it's done nothing but tank...still thinking charts apply to penny stocks is one of the funniest things I've ever heard....give it a rest dude and read some books on investing from people who are actually smart and know about MAKING MONEY.
Recent INM News
- InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 04/27/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:58:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:19:20 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/03/2026 08:17:05 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/31/2026 04:15:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:37:48 PM
- InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance • Newsfile • 03/27/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:26 AM
- InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program • Newsfile • 03/23/2026 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
- Sidoti Events, LLC's March Small-Cap Virtual Conference • ACCESS Newswire • 03/18/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:44 AM
- InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial • Newsfile • 03/09/2026 11:30:00 AM
- InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline • Newsfile • 03/06/2026 10:04:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2026 09:58:07 PM
- InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update • Newsfile • 02/11/2026 10:23:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/11/2026 10:04:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:42:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:41:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2025 04:41:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2025 04:55:06 PM
- InMed Announces Results of 2025 Annual General and Special Meeting • Newsfile • 12/18/2025 01:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/17/2025 05:20:20 PM
